# Serial Therapeutic and Antifungal Monitoring Protocol

> **NCT02163889** · — · COMPLETED · sponsor: **T2 Biosystems** · enrollment: 31 (actual)

## Conditions studied

- Candidemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02163889
- **Lead sponsor:** T2 Biosystems
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02163889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02163889, "Serial Therapeutic and Antifungal Monitoring Protocol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02163889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*